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Introduction {#pds3946-sec-0006}
============

Postcoital contraception or emergency contraception (EC) refers to the use of drugs or other interventions to prevent unwanted pregnancy after unprotected sexual intercourse.[1](#pds3946-bib-0001){ref-type="ref"}, [2](#pds3946-bib-0002){ref-type="ref"} EC differs from long‐term contraceptive measures, and is an extremely effective back‐up method in the instance of non‐use or failure of regular contraceptives.[2](#pds3946-bib-0002){ref-type="ref"} Currently, mifepristone and levonorgestrel (LNG) are the available hormonal EC drugs in Mainland China. Mifepristone can only be obtained with a prescription, thereby limiting its use in China. LNG in a single dose of 1.5 mg or two doses of 0.75 mg taken 12 h apart, which has superior efficacy and fewer adverse effects than the Yuzpe regimen, is the most widely used golden standard EC regimen in China.[3](#pds3946-bib-0003){ref-type="ref"}, [4](#pds3946-bib-0004){ref-type="ref"} Both dosage regimens have equal efficiency and safety, and have been reported to prevent unwanted pregnancies in 74--93% of the cases.[3](#pds3946-bib-0003){ref-type="ref"}, [5](#pds3946-bib-0005){ref-type="ref"} In 1998, levonorgestrel emergency contraception (LNG‐EC) was approved as an over‐the‐counter drug sold in China; currently, Chinese women prefer to directly purchase this drug from pharmacies than obtain EC from doctors.[6](#pds3946-bib-0006){ref-type="ref"} As LNG is extremely convenient, relatively safe, and well‐tolerated, it has now become the first line of hormonal EC among women of childbearing age. A sales analysis from the two largest Chinese pharmaceutical companies that manufacture and sell levonorgestrel emergency contraceptive pills (LNG‐ECPs) revealed that in the city of Shanghai, 790 000 boxes containing either 2 1.5‐mg or 4 0.75‐mg pills were sold in 2012 alone (Cheng, personal data).

However, with the widespread use of LNG‐EC, many concerns have been raised regarding the risk of ectopic pregnancy (EP) following LNG‐EC failure.[7](#pds3946-bib-0007){ref-type="ref"}, [8](#pds3946-bib-0008){ref-type="ref"}, [9](#pds3946-bib-0009){ref-type="ref"}, [10](#pds3946-bib-0010){ref-type="ref"} Not only is EP a leading cause of maternal morbidity and mortality worldwide but it is also a risk factor for recurrent EP and impaired fertility.[11](#pds3946-bib-0011){ref-type="ref"}, [12](#pds3946-bib-0012){ref-type="ref"} Our recent large‐sample multicenter study reported a sharp increase in the risk of EP following LNG‐EC failure compared to non‐users (adjusted odds ratio \[AOR\] = 5.29, 95% confidence interval \[CI\] = 4.07--6.87).[13](#pds3946-bib-0013){ref-type="ref"} Moreover, LNG‐EC misuse has been demonstrated to be correlated with a high risk of EP following LNG‐EC failure.[13](#pds3946-bib-0013){ref-type="ref"}

Westley *et al.* indicated that despite the growing use of emergency contraceptive pills (ECPs), proper information posed an important barrier to the desired impact on the unintended pregnancy rate.[14](#pds3946-bib-0014){ref-type="ref"} In another study, lack of awareness and misunderstanding about EC methods were shown to be the main obstacle to effective EC use.[15](#pds3946-bib-0015){ref-type="ref"} In general, the desired effect of EC can be produced only by correct use, which is closely correlated with knowledge about EC. Thus far, no studies have investigated the association between high risk for EP following LNG‐EC failure and knowledge of LNG‐EC. Therefore, we conducted a comparative survey among women with LNG‐EC failure to determine whether a correlation exists between the EP incidence following LNG‐EC and knowledge of LNG‐EC.

Materials and Methods {#pds3946-sec-0007}
=====================

Ethics statement {#pds3946-sec-0008}
----------------

This comparative survey was approved by the Institutional Review Board at the International Peace Maternity and Child Health Hospital, Shanghai, China. Written informed consents were obtained from all the subjects before recruitment. The participants were told that they could refuse the interview and withdraw from the study at any time, and that all information would be kept strictly confidential.

Participants {#pds3946-sec-0009}
------------

Women who presented at our hospital from March 2010 to April 2013 with a diagnosis of EP according to the unified diagnostic criteria (ACOG Practice Bulletin)[16](#pds3946-bib-0016){ref-type="ref"} were considered for participation in this comparative survey. Among these, women who had taken LNG‐EC since their last menstrual period were defined as having EP following LNG‐EC failure and were recruited to the EP group (EP following LNG‐EC failure).[17](#pds3946-bib-0017){ref-type="ref"} During the same period, patients who visited the pre‐abortion or early pregnancy clinics with intrauterine pregnancy (IUP) who had taken LNG‐EC since the last menstrual period were recruited to the IUP group (IUP following LNG‐EC failure). Patients in the IUP group were matched in age (±5 years), marital status, and gestational weeks (±7 days) at a ratio of 1:1 using their visiting numbers.

Data and sample collection {#pds3946-sec-0010}
--------------------------

After informed consents were obtained, the study participants were interviewed in person using a structured questionnaire covering sociodemographic characteristics (age, marital status, birth place, education attainment, occupation, individual annual income, and smoking status), reproductive and gynecological history (number of previous abortions, parity, previous EP, and results of the serum chlamydia trachomatis \[CT\] IgG test), surgical history (previous cesarean section, previous adnexal surgery, and appendectomy), previous contraceptive experience (OCPs, IUDs, ECPs, and condoms), key point of LNG‐EC, and sources of knowledge about LNG‐EC. Previous and current use of a certain contraceptive method was defined in line with the definitions in one of our previous studies.[17](#pds3946-bib-0017){ref-type="ref"} To assess the actual knowledge about LNG‐EC among women with LNG‐EC failure, an additional questionnaire consisting of 10 questions was specially designed. The questionnaire covered the mechanism of action, time frame, specific methods, complications of LNG‐EC when used in combination with other treatments and drug interactions. The participants were required to answer each question using Yes or No. To ensure a high completion rate and accuracy, the questionnaires were filled out by female researchers during the interview. In addition, blood samples were collected from each participant to test for serum *CT* IgG antibody using ELISA (Beijing Biosynthesis Biotechnology, China).

Statistical analysis {#pds3946-sec-0011}
--------------------

Pearson\'s chi‐square tests and *t*‐test were used to detect the difference between the EP group and IUP group in terms of the sociodemographic characteristics \[age (20--29, 30--39, or ≥40 years); marital status (married or unmarried); educational level (primary school or lower primary, middle school, high school, or university or above); occupation (employed, self‐employed, or unemployed); smoking status (non‐smoker, occasional smoker, or regular smoker)\], history of reproduction \[number of previous abortions (0, 1, 2, or ≥3); parity (0, 1, or ≥2)\], gynecology \[previous EP (no or yes); serum CT IgG test (negative or positive)\], surgery \[previous cesarean section (no or yes); previous adnexal surgery (no or yes); previous appendectomy (no or yes)\], previous contraceptive experience \[OCPs (no or yes); IUD (no or yes), ECPs (no or yes), and condoms (no or yes)\] and participants\' answer to each question. All statistical analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC). The *p* values were estimated by two‐sided tests, and the results were considered statistically significant when *p* \< 0.05.

Results {#pds3946-sec-0012}
=======

A total of 310 EP patients and 317 IUP women following LNG‐EC failure were included in this study. After eliminating 27 participants who declined entry or had incomplete information (10 in the EP group and 17 in the IUP group), 600 subjects (300 in the EP group and 300 in the IUP group) remained in the present study with a response rate of 95.69% (recruitment profile shown in Figure [1](#pds3946-fig-0001){ref-type="fig"}).

![Recruitment profile of subjects included in this study](PDS-25-880-g001){#pds3946-fig-0001}

Sociodemographic characteristics {#pds3946-sec-0013}
--------------------------------

Table [1](#pds3946-tbl-0001){ref-type="table-wrap"} lists the sociodemographic characteristics of the two groups. Significant differences were observed between the two groups in terms of their occupation (*p* \< 10^−4^) and educational attainment (*p* = 0.02). Apart from this, there were no statistical differences in the age, marital status, birth place, personal annual income, and smoking status between the two groups. The age of women (year; mean ± SD) was 27.05 ± 4.73 in the EP group and 27.50 ± 4.94 in the IUP group (data not shown in table). In addition, the gestational week (week; mean ± SD) of EP and IUP group were 6.78 ± 1.40 and 6.88 ± 1.80 respectively, and no significant difference was observed (*p* = 0.39) (data not shown in table).

###### 

Sociodemographic characteristics

  Variables                                                    EP following LNG‐EC failure (*N* = 300)  IUP following LNG‐EC failure (*N* = 300)    *p* Value          
  ----------------------------------------------------------- ----------------------------------------- ------------------------------------------ ----------- ------- ----------
  **Age (years)**                                                                                                                                                      0.18
  20--29                                                                         203                    67.67                                          183     61.00   
  30--39                                                                         94                     31.33                                          111     37.00   
  ⩾40                                                                             3                     1.00                                            6      2.00    
  **Marital status**                                                                                                                                                   0.10
  Married                                                                        185                    61.87                                          205     68.33   
  Unmarried                                                                      114                    38.13                                          95      31.67   
  **Birth place**                                                                                                                                                      0.47
  Shanghai                                                                       216                    72.00                                          208     69.33   
  Out of Shanghai                                                                84                     28.00                                          92      30.67   
  **Educational attainment**                                                                                                                                   0.02    
  Primary school or lower                                                        72                     24.00                                          47      15.67   
  Middle school                                                                  33                     11.00                                          29      9.67    
  High school                                                                    48                     16.00                                          41      13.67   
  University or above                                                            147                    49.00                                          183     61.00   
  **Occupation**                                                                                                                                                       \<10^−4^
  Employed                                                                       211                    70.33                                          251     83.67   
  Self‐employed                                                                  43                     14.33                                          14      4.67    
  Unemployed                                                                     46                     15.33                                          35      11.67   
  **Individual annual income (¥)**                                                                                                                                     0.13
  \<50 000                                                                       145                    48.33                                          125     41.67   
  50 000--100 000                                                                101                    33.67                                          103     34.33   
  \>100 000                                                                      54                     18.00                                          72      24.00   
  **Smoking status** [†](#pds3946-note-0004){ref-type="fn"}                                                                                                            0.18
  Non‐smoker                                                                     283                    94.33                                          274     91.95   
  Occasional smoker                                                               9                     3.00                                           18      6.04    
  Regular smoker                                                                  8                     2.67                                            6      2.01    

Note: EP = ectopic pregnancy, LNG‐EC = levonorgestrel emergency contraception, IUP = intrauterine pregnancy.

The sum does not necessarily equal the sample size for all variables because of missing data.

Occasional smoker: cigarette smoking more than 4 times a week, but a day on average less than 1 cigarette. Regular smoker: cigarette smoking more than 1 cigarettes per day, continuous or accumulated 6 months.

Reproductive, gynecological, surgical, and contraceptive history {#pds3946-sec-0014}
----------------------------------------------------------------

Table [2](#pds3946-tbl-0002){ref-type="table-wrap"} summarizes the difference in the reproductive, gynecological, surgical history, and previous contraceptive experience of these women between two groups. No significant differences were found in the number of previous abortions; previous EP; serum CT IgG test; surgical history including cesarean section, adnexal surgery, and appendectomy; and previous use of OCPs and ECPs. The parity differed significantly between both the groups (*p* = 0.01). Compared with the IUP group, previous IUD use was more common in the EP group (*p* = 0.03). Contrarily, the proportion of women who previously used condoms as contraception was significantly greater in IUP group than the EP group (*p* \< 10^−4^).

###### 

History of reproduction, gynecology, surgery, and contraceptive experiences

  Variables                                                               EP following LNG‐EC failure (*N* = 300)  IUP following LNG‐EC failure (*N* = 300)    *p* Value          
  ---------------------------------------------------------------------- ----------------------------------------- ------------------------------------------ ----------- ------- ----------
  **Reproductive history**                                                                                                                                                        
  **Number of previous abortions**                                                                                                                                                0.32
  0                                                                                         100                    34.25                                          85      28.33   
  1                                                                                         101                    34.59                                          110     36.67   
  2                                                                                         55                     18.84                                          56      18.67   
  ≥3                                                                                        36                     12.33                                          49      16.33   
  **Parity**                                                                                                                                                                      0.01
  0                                                                                         132                    45.21                                          162     54.18   
  1                                                                                         139                    47.60                                          129     43.14   
  ≥2                                                                                        21                     7.19                                            8      2.68    
  **Gynecologic history**                                                                                                                                                         
  **Previous EP**                                                                                                                                                                 1.00
  No                                                                                        291                    97.00                                          291     97.00   
  Yes                                                                                        9                     3.00                                            9      3.00    
  **Serum CT IgG test**                                                                                                                                                           0.40
  Negative                                                                                  264                    89.80                                          261     87.58   
  Positive                                                                                  30                     10.20                                          37      12.42   
  **Surgical history**                                                                                                                                                            
  **Previous cesarean section** [†](#pds3946-note-0007){ref-type="fn"}                                                                                                            0.43
  No                                                                                        85                     53.13                                          79      57.66   
  Yes                                                                                       75                     46.88                                          58      42.34   
  **Previous adnexal surgery**                                                                                                                                                    0.69
  No                                                                                        287                    95.67                                          287     96.31   
  Yes                                                                                       13                     4.33                                           11      3.69    
  **Previous appendectomy**                                                                                                                                                       0.54
  No                                                                                        285                    95.32                                          289     96.33   
  Yes                                                                                       14                     4.68                                           11      3.67    
  **Previous contraceptive experiences**                                                                                                                                          
  **OCPs**                                                                                                                                                                        0.08
  No                                                                                        287                    95.99                                          278     92.67   
  Yes                                                                                       12                     4.01                                           22      7.33    
  **IUDs**                                                                                                                                                                        0.03
  No                                                                                        270                    90.30                                          285     95.00   
  Yes                                                                                       29                     9.70                                           15      5.00    
  **ECPs**                                                                                                                                                                        0.07
  No                                                                                        24                     8.14                                           38      12.71   
  Yes                                                                                       271                    91.86                                          261     87.29   
  **Condom**                                                                                                                                                                      \<10^−4^
  No                                                                                        133                    44.63                                          71      23.67   
  Yes                                                                                       165                    55.37                                          229     76.33   

Note: EP = ectopic pregnancy, IUP = intrauterine pregnancy, LNG‐EC = levonorgestrel emergency contraception, CT = chlamydia trachomatis, OCPs = oral contraceptive pills, IUDs = intrauterine devices, ECPs = emergency contraceptive pills.

The sum does not necessarily equal the sample size for all variables because of missing data.

The number of women having delivered a child (160 women in the EP group and 137 women in the IUP group) was used as the denomintor to calculate the percentage.

Knowledge about LNG‐EC {#pds3946-sec-0015}
----------------------

The present study focuses on women who became pregnant following LNG‐EC failure in the current cycle; therefore, all the participants replied "Yes" to the question, "Have you ever heard of LNG‐EC?" (data not shown). Table [3](#pds3946-tbl-0003){ref-type="table-wrap"} presents the results of 10 closed questions. Women who mistakenly assumed that LNG‐EC was an abortion pill were more likely to experience EP following LNG‐EC failure than women who did not have this misconception (*p* = 0.04); 62.37% and 34.35% of women in EP group and IUP group, respectively, were unaware that further unprotected sexual intercourse after use of LNG‐EC should be avoided (*p* \< 10^−4^). Women who agreed with the repeated use of LNG‐ECPs in the same cycle were more likely to suffer EP after LNG‐EC failure (*p* \< 10^−4^). Compared with women who took LNG‐ECPs strictly according to a healthcare professional\'s advice or according to package instructions, those who did not strictly follow guidelines and instructions were significantly more likely to experience EP following LNG‐EC failure (*p* \< 10^−4^). However, ignorance of the treatment window posed no risk for EP (*p* = 0.14). Unfamiliarity with possibility of EP as a consequence of LNG‐EC failure (*p* = 0.92), complications of ECPs including abnormal uterine bleeding (*p* = 0.81), menstrual cycle changes (*p* = 0.89), and drug interactions (*p* = 0.10) had no association with the occurrence of EP following LNG‐EC. Women who did not know how to deal with vomiting within 2 h after LNG‐ECPs use had higher risk for EP (*p* \< 10^−2^).

###### 

Knowledge about LNG‐EC

  Questions                                                                                                           EP following LNG‐EC failure (*N* = 300)  IUP following LNG‐EC failure (*N* = 300)    *p* Value          
  ------------------------------------------------------------------------------------------------------------------ ----------------------------------------- ------------------------------------------ ----------- ------- ----------
  LNG‐ECPs are not another term for "abortion pills".                                                                                                                                                                         0.04
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            281                    95.25                                          295     98.33   
  No                                                                                                                                    14                     4.75                                            5      1.67    
  LNG‐ECPs should be taken within 72 h and up to 120 h after unprotected sexual intercourse.                                                                                                                                  0.14
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            240                    81.91                                          259     86.33   
  No                                                                                                                                    53                     18.09                                          41      13.67   
  Further act of unprotected sexual intercourse after use of LNG‐ECPs in the same menstrual cycle is inapproriate.                                                                                                            \<10^−4^
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            111                    37.63                                          193     65.65   
  No                                                                                                                                    184                    62.37                                          101     34.35   
  LNG‐ECPs cannot be used repeatedly in the same menstrual cycle.                                                                                                                                                             
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            224                    75.93                                          276     93.24   \<10^−4^
  No                                                                                                                                    71                     24.07                                          20      6.76    
  EP may occur as a result of LNG‐EC failure.                                                                                                                                                                                 
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            179                    60.27                                          182     60.67   0.92
  No                                                                                                                                    118                    39.73                                          118     39.33   
  Did you take LNG‐ECPs this time in strict accordance with the drug instruction or doctors\' advice?                                                                                                                         
  Yes                                                                                                                                   115                    38.46                                          192     64.00   \<10^−4^
  No                                                                                                                                    184                    61.54                                          108     36.00   
  Abnormal uterine bleeding may occur after the use of LNG‐ECPs.                                                                                                                                                              
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            133                    44.33                                          130     43.33   0.81
  No                                                                                                                                    167                    55.67                                          170     56.67   
  Taking LNG‐ECPs may cause changes in your menstrual cycle.                                                                                                                                                                  
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            161                    54.21                                          161     53.67   0.89
  No                                                                                                                                    136                    45.79                                          139     46.33   
  If you vomit within 2 h after the use of LNG‐ECPs, you should take another pill immediately.                                                                                                                                
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            79                     27.15                                          117     39.39   \<10^−2^
  No                                                                                                                                    212                    72.85                                          180     60.61   
  LNG‐ECPs may have drug interaction with other drugs.                                                                                                                                                                        
  Yes[\*](#pds3946-note-0010){ref-type="fn"}                                                                                            58                     22.14                                          79      28.21   0.10
  No                                                                                                                                    204                    77.86                                          201     71.79   

Note: LNG‐EC = levonorgestrel emergency contraception, EP = ectopic pregnancy, IUP = intrauterine pregnancy, LNG‐ECPs = levonorgestrel emergency contraceptive pills, OR = odds ratio, CI = confidence interval, AOR = adjusted odds ratio.

The sum does not necessarily equal the sample size for all variables because of missing data.

Indicates the correct answer.

Sources of knowledge about emergency contraception {#pds3946-sec-0016}
--------------------------------------------------

In the EP group, a similar number of women reported acquiring knowledge about LNG‐EC from friends/peers and TV (68/300, 22.67%) and the Internet (56, 18.67%; Table [4](#pds3946-tbl-0004){ref-type="table-wrap"}). In the IUP group, the most common source of LNG‐EC was friends/peers (30.46%) followed by the Internet (18.21%) and TV (15.56%). Notably, women from both the groups were least likely to learn about LNG‐EC from medical staff (EP group: 2.67% and IUP group: 2.65%). In contrast, a higher proportion of women obtained knowledge of LNG‐EC from retail pharmacy staff (EP group: 17.00% and IUP group: 9.93%). There was no significant difference in the distribution of sources (*p* = 0.07).

###### 

Sources of knowledge about LNG‐EC

  Variables                                                                              EP following LNG‐EC failure (*n* = 300)  IUP following LNG‐EC failure (*n* = 300)    *p* Value          
  ------------------------------------------------------------------------------------- ----------------------------------------- ------------------------------------------ ----------- ------- ------
  **Where did you mainly learn about LNG‐EC?** [†](#pds3946-note-0013){ref-type="fn"}                                                                                                            0.07
  Internet                                                                                                 56                     18.67                                          54      18.21   
  TV                                                                                                       68                     22.67                                          47      15.56   
  Print                                                                                                    17                     5.67                                           32      10.60   
  Friends/Peers                                                                                            68                     22.67                                          91      30.46   
  Family                                                                                                   32                     10.67                                          38      12.58   
  Medical staff                                                                                             8                     2.67                                            8      2.65    
  Retail pharmacy staff                                                                                    51                     17.00                                          30      9.93    

Note: LNG‐EC = levonorgestrel emergency contraception, EP = ectopic pregnancy, IUP = intrauterine pregnancy, OR = odds ratio, CI = confidence interval.

The sum does not necessarily equal the sample size for all variables because of missing data.

The question is an one‐choice question.

Discussion {#pds3946-sec-0017}
==========

In this study, we found that unaware of the mechanism and proper use of LNG‐ECPs and non‐compliance with medicine instruction or doctors\' advice may contribute to the occurrence of EP following LNG‐EC failure. Among women with LNG‐EC failure, "friends/peers", "TV", and "Internet" are the main sources of information of LNG‐EC.

Despite the increasing and widespread use of ECPs in many countries, it does not appear to reduce the rate of unintended pregnancy as desired.[14](#pds3946-bib-0014){ref-type="ref"}, [18](#pds3946-bib-0018){ref-type="ref"} Wang pointed out that the prevalence, reliability, and continuity of contraceptive use are critical for effective contraception, and particularly, the role of contraceptive failure as a fertility determinant has become increasingly highlighted.[19](#pds3946-bib-0019){ref-type="ref"} In particular, unlike other contraceptives, there are many requirements for taking hormonal EC such as the dose, time frame, time between coitus and administration, action after pill use, and solutions for relevant complications. The efficacy of LNG‐ECPs depends mostly on users\' discipline and control; thus, the failure rate is high.[19](#pds3946-bib-0019){ref-type="ref"} One of our previous studies indicated that the main reasons for the continuing cases of EP following LNG‐EC failure are the easy accessibility and wide marketing of LNG‐EC, and the use of LNG‐EC without following drug instructions.[13](#pds3946-bib-0013){ref-type="ref"} Apart from the lack of awareness of EC, correct use often remains low in places where people are familiar with ECPs, and this is attributed to the poor knowledge on fertility, contraception, and pregnancy risk.[14](#pds3946-bib-0014){ref-type="ref"} To our knowledge, this is the first study concerning the association between knowledge of LNG‐EC and the risk of EP following LNG‐EC failure.

We demonstrated that women who were unaware of the mechanism of ECPs as inhibiting or delaying ovulation rather than inducing abortion were at a high risk of EP following LNG‐EC failure.[20](#pds3946-bib-0020){ref-type="ref"} Wrong answers to this basic question reflect the terribly poor general knowledge about LNG‐EC. Improper use of ECPs as a result of lack of knowledge, including repeated use of ECPs and further unprotected intercourse within the same cycle and no use of another pill as a remedial measure for vomiting may not only lead to LNG‐EC failure but also increase the risk of EP following LNG‐EC failure. LNG is a synthetic progestin analogue that is a highly efficient postcoital contraceptive, and it functions by interrupting follicular development and consequently delaying or inhibiting ovulation.[21](#pds3946-bib-0021){ref-type="ref"} Moreover, it affects the human fallopian tube by reducing smooth muscle motility and cilia beat,[22](#pds3946-bib-0022){ref-type="ref"}, [23](#pds3946-bib-0023){ref-type="ref"} and a reduction of tubal activity was considered as a main mechanism of embryo‐tubal retention and implantation.[24](#pds3946-bib-0024){ref-type="ref"} When taking LNG‐ECPs repeatedly following fertilization, the zygote is more likely to be detained and implant in the fallopian tube.[13](#pds3946-bib-0013){ref-type="ref"} If further unprotected intercourse occurs, the ovulated ovum that would linger as a result of the previous LNG‐ECPs may become fertilized.[13](#pds3946-bib-0013){ref-type="ref"} In fact, among 600 women recruited in our study, no one vomited within 2 h after the use of LNG‐ECPs (data not shown in table). Therefore, although the number of women who know the correct remedial measure after the puke was much more in IUP group, the answers to this question may not demonstrate the relation between not taking another pill and EP but reflect EP women\'s poorer knowledge about LNG‐EC. As demonstrated in this study, women who adhered to drug instructions or healthcare professionals\' advice were found to have a lower risk of EP as a consequence of LNG‐EC failure. Thus, women should use LNG‐ECPs under doctors\' advice or strictly comply with the package instructions. Despite the evidence showing a sharp increase in EP following LNG‐EC failure,[13](#pds3946-bib-0013){ref-type="ref"} nearly 40% of the participants did not realize the potential risks of EP associated with incorrect use of LNG‐ECPs (EP and IUP groups: 39.73% and 39.33% respectively); however, ignorance of this fact was not associated with any risk of EP. From the dominant follicular selection to the rise of luteinizing hormone peak, the timeframe at which LNG‐EC can be used is rather narrow and this hinders EC use.[3](#pds3946-bib-0003){ref-type="ref"}, [25](#pds3946-bib-0025){ref-type="ref"} It has been well demonstrated that the efficacy of LNG‐ECPs decreases significantly with time after coitus.[4](#pds3946-bib-0004){ref-type="ref"} A meta‐analysis indicated that women taking LNG within 72 h were less likely to pregnant compared to those took LNG after 72 h (RR = 0.51, 95% CI: 0.3--0.84).[26](#pds3946-bib-0026){ref-type="ref"} Despite the lack of a concrete timeframe there was no relation to EP, and as indicated here, LNG‐ECPs should be used as soon as possible following unprotected intercourse because its efficacy weakens over time.[27](#pds3946-bib-0027){ref-type="ref"}

A 2003 study in Hong Kong showed that 63.7% of Chinese women who visited birth control clinics and healthcare centers had heard about EC before and most subjects had learned about EC from the media (52.8%) and friends (23.5%).[28](#pds3946-bib-0028){ref-type="ref"} Chen Y *et al.* found that in Shanghai, EC awareness among women of childbearing age was as high as 90.29%, which was much higher than the data obtained in 1989 (28.6%).[29](#pds3946-bib-0029){ref-type="ref"} In the UK, although 91% of women had heard about "the morning‐after pill", its usage rate was as low as 7%.[14](#pds3946-bib-0014){ref-type="ref"} In another study, Westley *et al.* highlighted the role of the media in spreading misconceptions regarding EC by giving examples that BBC and an American mainstream newspaper conveying wrong messages.[14](#pds3946-bib-0014){ref-type="ref"}As demonstrated in the present study, TV (22.67%) and friends/peers (22.67%) are two main ways by which women in the EP group learned about EC, while women in the IUP group reported that they learned about EC from friends/peers (30.46%). Furthermore, retail pharmacy staff was a more general source of EC awareness in the case group. This finding is in accordance with findings in a previous study in which 43.06% of the customers seeking ECPs from pharmacists did not have complete information on its correct use.[29](#pds3946-bib-0029){ref-type="ref"} It was previously found that when patients visited pharmacies to obtain ECPs, pharmacy‐related barriers occurred 30% of the time, including the time for finding knowledgeable pharmacy staff.[30](#pds3946-bib-0030){ref-type="ref"} We presumed that the incomplete or incorrect information supplied by pharmacists or on TV may lead to the inappropriate use of ECPs, thus increasing the chance of EP following LNG‐EC failure. Therefore, consistent with other studies,[31](#pds3946-bib-0031){ref-type="ref"}, [32](#pds3946-bib-0032){ref-type="ref"} our findings indicate that retail pharmacy staff should be systematically educated in detail on EC and be encouraged to counsel women on EC and the correct use of ECPs. Media should be used to disseminate correct information about EC. Less than 3% (16/600) of the women in the study obtained information about EC from medical staff, which is potentially the most reliable source of information. This is mainly because of the easy accessibility of ECPs from pharmacies, and partly because of doctors lack time to discuss EC with patients, and partly because of the private nature of the subject.[33](#pds3946-bib-0033){ref-type="ref"}

It is important to note that this study has some limitations. The coverage of our study on the knowledge of EC was not sufficiently extensive: although the participants\' compliance rate was high, we did not investigate the truth of the knowledge conveyed by healthcare professionals or media. Whether the participants acted in accordance with certain correct key points remains unknown.

Conclusions {#pds3946-sec-0018}
===========

We found that in cases of pregnancy after LNG‐EC failure, women who lacked awareness on the correct usage of LNG‐EC were at a high risk of EP following LNG‐EC failure. Therefore, we recommend that women use LNG‐EC only in strict accordance with the guidance of healthcare professionals. Various media should be used to disseminate relevant information about responsible EC, and pharmacy staff and pharmacists should receive regular educational training sessions on the subject of EC.
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